Search

Background: In February and Mach 2020, two mass swab testing campaigns conducted in Vo’, Italy demonstrated the extent of asymptomatic SARS-CoV-2 infection and the feasibility of epidemic suppression. Methods: We tested 86% of the Vo’ population (2,602 subjects) in May with three immuno-assays detecting antibodies against the spike (S) and nucleocapsid (N) antigens, a neutralisation assay and Polymerase Chain Reaction (PCR). Subjects testing positive to PCR in February/March or a serological assay in May were tested again in November. Findings: Combining the results obtained with the three assays, we estimate a seroprevalence of 3.5% (95% Credible Interval (CrI) 2.8%-4.3%) in May. In November, all assays showed a reduction in antibody titres, though 98.8% (95% Confidence Interval (CI) 93.7%-100.0%) of sera still reacted against at least one antigen. Conversely, 18.6% (95% CI 11.0%-28.5%) showed a marked increase of antibody or viral neutralisation reactivity between May and November, linked to documented or likely re-exposures. We found significant differences in the magnitude and persistence of the antibody response by age group but not by symptom occurrence, hospitalisation, or sex. Analysis of the serostatus of 1,118 households indicated a 27.3% (95% CrI 19.2%-34.6%) probability of SARS-CoV-2 transmission among household members and that 81.8% (95% CrI 55.9%-95.2%) of transmission could be attributed to 20% of infections. Contact tracing correctly identified 44% of the infected subjects and had limited impact on the epidemic. Interpretation: We find evidence of antibody persistence up to nine months post infection. Different assays provided significantly different seroprevalence estimates, making it challenging to compare seroprevalence estimates globally. Due to the high population susceptibility and the limited impact of contact tracing, rigorous testing and improvements in contact tracing are essential to control SARS-CoV-2. Funding: Veneto Region, Medical Research Council, Wellcome Trust, Royal Society, University of Padua, UK National Institute for Health Research. Declaration of Interests: The authors declare no competing interests. Ethics Approval Statement: The first and second serosurveys of the Vo' population were approved by the Ethics Committee for Clinical Research of the province of Padova.

Background Since 2010 Veneto region (North-Eastern Italy) planned a special integrated surveillance of summer fevers to promptly identify cases of West Nile Fever (WNF), dengue (DENV) and chikungunya (CHIKV). The objectives of this study were (i) To increase the detection rate of imported CHIKV and DENV cases in travellers from endemic areas and promptly identify potential autochthonous cases.(ii) To detect autochthonous cases of WNF, besides those of West Nile Neuroinvasive Disease (WNND) that were already included in a national surveillance. Methods Human surveillance: a traveler who had returned within the previous 15 days from endemic countries, with fever >38°C, absence of leucocytosis (leukocyte count 38°C for

In 2009, six new human cases of West Nile neuroinvasive disease (WNND) were identified in Veneto region, following the six cases already reported in 2008. A human West Nile virus (WNV) isolate was obtained for the first time from an asymptomatic blood donor. Whole genome sequence of the human WNV isolate showed close phylogenetic relatedness to the Italy-1998-WNV strain and to other WNV strains recently isolated in Europe, with the new acquisition of the NS3-Thr249Pro mutation, a trait associated with avian virulence, increased virus transmission, and the occurrence of outbreaks in humans.

Três experimentos foram realizados para verificar se o local de aplicação de fomesafen, folhas ou solo, afeta a eficácia desse herbicida em biótipos de E. heterophylla resistente e suscetível a ele; e determinar quais estruturas da planta são mais importantes no processo de absorção desse herbicida. Nos dois primeiros experimentos, testaram-se curvas de dose-resposta de fomesafen em biótipos com e sem resistência a inibidores da PROTOX, em pré-emergência (primeiro experimento) e em pós-emergência (segundo experimento). No terceiro experimento, diferentes locais de deposição de fomesafen foram avaliados, por meio do método de vaso duplo, para verificar quais as estruturas das plantas de E. heterophylla mais importantes na absorção do herbicida. Os resultados, em geral, indicam menor eficiência de controle quando o fomesafen é aplicado na parte aérea das plantas de E. heterophylla resistentes a esse herbicida, em comparação às suscetíveis, e que as diferenças entre os biótipos foram menores na aplicação em pré-emergência. Detectou-se maior eficiência do herbicida fomesafen aplicado ao solo quando este foi colocado junto à parte aérea emergente das plantas suscetíveis e resistentes do que junto ao sistema de raízes destas. Esses resultados apóiam a hipótese de que diferenças foliares entre plantas resistentes e suscetíveis podem dificultar a absorção de fomesafen nos biótipos resistentes aos inibidores da PROTOX. Three trials were carried out to verify if the site of formesafen, absorption leaves or soil, affects the efficacy of controling this herbicide in wild poinsettia biotypes resistant and susceptible to the product; and to determine which plant structures are more important for fomesafen absorption. In the first two trials, fomesafen dose-response was evaluated on biotypes susceptible and resistant to PROTOX inhibitors, in the pre (first trial) and post emergence (second trial) applications. In a third trial, different deposition sites of fomesafen were evaluated using the double pot system to verify the structures of wild poinsettia plants which were most important to fomesafen absorption. Overall, the results indicated that shoot absorption of fomesafen was more limited on wild poinsettia biotypes with PROTOX resistance than on susceptible ones and that these differences between biotypes were less important when applied in pre-emergence. When applied to soil, fomesafen efficacy increased when the herbicide was placed near wild poinsettia shoots than close to their roots. These results support the hypothesis that leaf differences between resistant and susceptible plants may limit fomesafen absorption on biotypes resistant to PROTOX inhibitors.